Publicaciones en las que colabora con María Sánchez Ledesma (26)

2021

  1. Endocarditis infecciosa: retos actuales y perspectiva futura

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 156-159

  2. Infectious endocarditis: current challenges and future perspectives

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 156-159

2020

  1. Dispositivos de asistencia circulatoria e infecciones asociadas:: nuevas terapias, nuevas complicaciones

    Revista Española de Casos Clínicos en Medicina Interna (RECCMI), Vol. 5, Núm. 1, pp. 36-38

  2. Gestión de las salas de procedimientos invasivos cardiológicos durante el brote de coronavirus COVID-19: Documento de consenso de la Asociación de Cardiología Intervencionista y la Asociación del Ritmo Cardiaco de la Sociedad Española de Cardiología

    REC: Interventional Cardiology, Vol. 2, Núm. 2, pp. 106-111

  3. Hemorragia espontánea de origen incierto

    Revista Española de Casos Clínicos en Medicina Interna (RECCMI), Vol. 5, Núm. 2, pp. 74-77

  4. Infective Endocarditis after Transvalvular Aortic Replacement: A call for a joined effort to improve its results

    Enfermedades Infecciosas y Microbiologia Clinica

  5. Prevention of infective endocarditis and clinical practice guidelines: From theory to real clinical practice.

    European Journal of Internal Medicine

2013

  1. Effect of elevated pulmonary vascular resistance on outcomes after percutaneous mitral valvuloplasty

    American Journal of Cardiology, Vol. 112, Núm. 4, pp. 580-584

2011

  1. Difference in outcome among women and men after percutaneous mitral valvuloplasty

    Catheterization and Cardiovascular Interventions, Vol. 77, Núm. 1, pp. 115-120

2010

  1. Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction

    Diabetes Research and Clinical Practice, Vol. 88, Núm. 1, pp. 97-102

2009

  1. An association between resistant hypertension and the null GSTM1 genotype

    Journal of Human Hypertension, Vol. 23, Núm. 8, pp. 556-558

  2. Association between -T786C NOS3 polymorphism and resistant hypertension: A prospective cohort study

    BMC Cardiovascular Disorders, Vol. 9

  3. Heparin-Induced Thrombocytopenia

    Pharmacology in the Catheterization Laboratory (Wiley-Blackwell), pp. 261-269

  4. Impact of Pre- and Postprocedural Mitral Regurgitation on Outcomes After Percutaneous Mitral Valvuloplasty for Mitral Stenosis

    American Journal of Cardiology, Vol. 104, Núm. 8, pp. 1122-1127

  5. Left atrial appendage exclusion using an Amplatzer device

    International Journal of Cardiology, Vol. 134, Núm. 1

  6. Predicting Success and Long-Term Outcomes of Percutaneous Mitral Valvuloplasty: A Multifactorial Score

    American Journal of Medicine, Vol. 122, Núm. 6

2008

  1. Complicaciones macrovasculares del paciente diabético. Pie diabético

    Medicine, Vol. 10, Núm. 17, pp. 1110-1124

  2. Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome

    Journal of Thrombosis and Thrombolysis, Vol. 25, Núm. 2, pp. 214-218

  3. Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction: Molecular Diagnosis

    Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 3, pp. 955-961

  4. Impact of concomitant aortic regurgitation on percutaneous mitral valvuloplasty: Immediate results, short-term, and long-term outcome

    American Heart Journal, Vol. 156, Núm. 2, pp. 361-366